Evidence map›Paper›PMID 37895408›Full record

ArticleLife (Basel, Switzerland)2023

The CHA

Nicholay Teodorovich, Gera Gandelman, Michael Jonas, Yakov Fabrikant, Michael Sraia Swissa, Sara Shimoni, Jacob George, Moshe Swissa

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Prognostic value of HELT-ECardiovascular intervention and therapeutics · 2025
    Observational
  2. Observational
  3. CHATherapeutics and clinical risk management · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Nicholay TeodorovichKaplan Medical Center, Rehovot and the Hebrew University, Jerusalem 7661041, Israel.
Gera GandelmanKaplan Medical Center, Rehovot and the Hebrew University, Jerusalem 7661041, Israel.
Michael JonasKaplan Medical Center, Rehovot and the Hebrew University, Jerusalem 7661041, Israel.
Yakov FabrikantKaplan Medical Center, Rehovot and the Hebrew University, Jerusalem 7661041, Israel.
Michael Sraia SwissaShari-Zedek Medical Center, and the Hebrew University, Jerusalem 9103102, Israel.
Sara ShimoniKaplan Medical Center, Rehovot and the Hebrew University, Jerusalem 7661041, Israel.
Jacob GeorgeKaplan Medical Center, Rehovot and the Hebrew University, Jerusalem 7661041, Israel.
Moshe SwissaKaplan Medical Center, Rehovot and the Hebrew University, Jerusalem 7661041, Israel.
Kaplan Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe CHA METHODS AND

resultsThis was a prospective study of 990 patients undergoing coronary angiography. The median follow-up was 2294 days. The patients were categorized into two groups according to their CHA

conclusionsThe CHA

Indexed as

CHA2DS2-VASC scorecoronary angiographymortalityoutcomes

Identifiers

PMID37895408
PMCPMC10608546
OpenAlexW4387459090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.